Research on whether dietary fiber raises GLP-1 illustrates why a proposed effect on the hormone cannot establish that a product changes appetite or weight. There is no established weight-loss benefit for retail patches marketed as “natural GLP-1.” A survey documented 24 patches and one gel sold under that idea.[1]
What the retail labels listed
Products in the survey listed an average of seven ingredients. Berberine, glutamine or glutamate, cinnamon and pomegranate were among the most common. Researchers examined labels and marketing and found no posted certificates of analysis. They did not test the contents or how much of each ingredient reaches the bloodstream through skin.[1]
What researchers have tested in people
A meta-analysis of randomized trials estimated that oral berberine lowered body weight by an average of 0.88 kg compared with controls (95% CI 0.39–1.36 kg lower). A separate six-month randomized trial of 337 adults with obesity and metabolic dysfunction–associated steatotic liver disease found no significant difference in visceral fat or liver fat between oral berberine and placebo. Neither study evaluated a patch.[2][3]
Where prescription patch research stands
The U.S. Wegovy label lists an injection and an oral tablet. Our guide to how semaglutide tablets and injections are absorbed explains why the delivery route matters. In July 2026, Terrestrial Bio announced that it had started dosing participants in a phase 1 study of its investigational semaglutide microarray patch. That trial concerns the sponsor’s specific device and formulation and offers no evidence about the retail products in the survey.[4][5]
What the label can tell you about safety
The FDA’s definition of dietary supplements covers products intended to be swallowed and excludes topical products.[6] A product name or ingredient list alone cannot establish how much a patch delivers, whether it works, or how safe it is to use alongside a medication.